Retracted: Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms
Biomed Res Int. 2024 Mar 20:2024:9846925.
doi: 10.1155/2024/9846925.
eCollection 2024.